Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title |
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism
|
Education | Internal Medicine | All | |
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
|
Education | Health Equity | China | |
Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
|
Education | Rare Disease | USA | |
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
Quality Improvement | Rare Disease | USA | |
Quality Improvement Grants to improve the early suspicion, identification, and the management of patients with ATTR-CM
Release Date:
|
Quality Improvement | Rare Disease | Canada | |
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
|
Education | Vaccines | Japan | |
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
|
Quality Improvement | Vaccines | Italy | |
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
|
Quality Improvement | Oncology | Japan | |
Sickle Cell Disease (SCD) Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
Cancer Registry
Release Date:
|
Research | Oncology | Congo, The Democratic Republic | |
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
|
Research | Inflammation & Immunology | China | |
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
|
Research | Inflammation & Immunology | China |
| Title |
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Transition of Care in VTE
Release Date:
|
||||
Anticoagulation Education - NVAF or VTE
Release Date:
|
||||
Achievement of Treat-to-Target in Rheumatoid Arthritis
Release Date:
|
||||
Improving Care of Chronic Pain- Physician Groups and Health Systems
Release Date:
|
||||
Facilitation of the Diagnosis of Rheumatoid Arthritis
Release Date:
|
||||
Pfizer and NCCN: Metastatic Breast Cancer
Release Date:
|
||||
Pediatric Immunization Series Completion
Release Date:
|
||||
Pfizer and National Psoriasis Foundation (NPF): Plugging the Treatment Gap in Psoriasis and Psoriatic Arthritis
Release Date:
|
||||
Pfizer and International Atherosclerosis Society (IAS): Lipid Management in High-Risk Patients
Release Date:
|
||||
Pfizer and American Academy of Dermatology (AAD): Patient Access to Care
Release Date:
|
||||
Narrowing the Time Gap between Onset of Symptoms and Treatment for Rheumatoid Arthritis
Release Date:
|